Pre-treatment carbohydrate antigen 19-9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer
about
Neoadjuvant therapy for localized pancreatic cancer: guiding principlesNeoadjuvant treatment sequencing adds value to the care of patients with operable pancreatic cancer.Analysis of Predictors of Resection and Survival in Locally Advanced Stage III Pancreatic Cancer: Does the Nature of Chemotherapy Regimen Influence Outcomes?
P2860
Pre-treatment carbohydrate antigen 19-9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pre-treatment carbohydrate ant ...... th localized pancreatic cancer
@ast
Pre-treatment carbohydrate ant ...... th localized pancreatic cancer
@en
type
label
Pre-treatment carbohydrate ant ...... th localized pancreatic cancer
@ast
Pre-treatment carbohydrate ant ...... th localized pancreatic cancer
@en
prefLabel
Pre-treatment carbohydrate ant ...... th localized pancreatic cancer
@ast
Pre-treatment carbohydrate ant ...... th localized pancreatic cancer
@en
P2093
P2860
P356
P1476
Pre-treatment carbohydrate ant ...... th localized pancreatic cancer
@en
P2093
Ashley N Krepline
Ben George
Beth A Erickson
Douglas B Evans
Kathleen K Christians
Mohammed Aldakkak
Paul S Ritch
Susan Tsai
P2860
P304
P356
10.1111/HPB.12448
P577
2015-08-10T00:00:00Z